E8-25471. Amendments to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals; Final Rule; Correction
-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Final rule; correction.
SUMMARY:
The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of Monday, September 8, 2008 (73 FR 51919). The final rule was published with an inadvertent error in the “Analysis of Impacts” section. This document corrects that error.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Diane Sullivan, Office of Policy (HF-26), Food and Drug Administration, 5600 Fishers Lane, rm. 12A-11, Rockville, MD 20857, 301-827-7069, e-mail: diane.sullivan@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In FR Doc. E8-20709, appearing on page 51919 in the Federal Register of Monday, September 8, 2008, the following correction is made:
1. On page 51931, in the first column, under “IV. Analysis of Impacts,” in the first full paragraph, the sentence “The agency believes that this final rule is not a significant regulatory action as defined by the Executive order, because the rule either clarifies the agency's longstanding interpretation of, or increases latitude for manufacturers in complying with, existing CGMP requirements” is corrected to read “The agency certifies that this final rule is not a significant regulatory action as defined by the Executive order, because the rule either clarifies the agency's longstanding interpretation of, or increases latitude for manufacturers in complying with, existing CGMP requirements.”
Start SignatureStart Printed Page 63362End Signature End Supplemental InformationDated: October 16, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E8-25471 Filed 10-23-08; 8:45 am]
BILLING CODE 4160-01-S
Document Information
- Comments Received:
- 0 Comments
- Published:
- 10/24/2008
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final rule; correction.
- Document Number:
- E8-25471
- Pages:
- 63361-63362 (2 pages)
- Docket Numbers:
- Docket No. FDA-2007-N-0379
- PDF File:
- e8-25471.pdf
- CFR: (2)
- 21 CFR 210
- 21 CFR 211